Pemvidutide Reconstitution Calculator
Enter the amount you want to measure. The vial buttons will highlight which vial strengths create cleaner syringe-unit measurements.
What amount do you need?
Type the target amount, then choose mg or mcg. Example: 2mg or 500mcg.
Syringe size:
Possible vial strengths:
Best Match
Good Match
Usable
Harder to Measure
Example Pemvidutide Titration Schedule
| Parameter | Details |
|---|---|
| Dosage | 1.2 mg, 1.8 mg, or 2.4 mg per injection |
| Route | Subcutaneous (SC) |
| Frequency | Once weekly |
| Cycle Length | 24–48 weeks (clinical trials) |
| Half‑life | Extended (~7 days) via EuPort™ albumin-binding domain |
| Titration | None required (direct start at target dose) |
Possible vial strengths:
What Is It?
Pemvidutide
Dual GLP-1 / glucagon agonist in metabolic research.
Bacteriostatic Water
Sterile water containing a bacteriostatic preservative, commonly used when preparing multi-use research vials.
How To Mix Pemvidutide
1
CleanUse alcohol swabs to clean the tops of both vials.
2
Draw BAC WaterDraw the selected amount of bacteriostatic water.
3
Inject SlowlyAdd the liquid slowly down the side of the vial.
4
Swirl GentlyDo not shake. Swirl gently until dissolved.
5
Store ProperlyStore as directed and protect from heat and light.
Best Practices & Common Mistakes
Best Practices
- Use sterile technique.
- Protect from light and heat.
- Store refrigerated when appropriate.
- Use clean syringe-unit math before measuring.
Common Mistakes
- Confusing milligrams with milliliters.
- Choosing an option with awkward decimal units.
- Using too little liquid for very small measurements.
- Shaking the vial aggressively.
Pemvidutide Storage & Handling
Lyophilized Powder: −20°C (−4°F) for long-term storage (up to 24 months). Refrigeration 2–8°C (36–46°F) for short-term use (up to ~3 months). Original sealed vial in the freezer is safest.
Reconstituted Solution: 2–8°C (36–46°F), use within ~7–14 days. Keep sealed, avoid light, and do not repeat freeze-thaw cycles.
Reconstituted Solution: 2–8°C (36–46°F), use within ~7–14 days. Keep sealed, avoid light, and do not repeat freeze-thaw cycles.
Frequently Asked Questions
Yes. The calculator's default daily schedule would cause dangerous accumulation. Pemvidutide is specifically engineered for once‑weekly subcutaneous injection, with clinical trials using doses of 1.2, 1.8, and 2.4 mg per week.
Pemvidutide has low water solubility due to its large size (3873.35 g/mol), lactam bridge, and 17‑carboxyheptadecyl fatty acid chain. Standard BAC water will likely leave it cloudy. Specialist suppliers recommend first dissolving in DMSO, then using a multi‑component vehicle (e.g., DMSO : PEG300 : Tween‑80 : saline = 10 : 40 : 5 : 45) to achieve a clear injectable solution.
Yes, but with a catch. The lyophilised powder is stable for 3 years at ‑20 °C. Once reconstituted, the solution is stable at 2‑8 °C for 24 months (the labelled shelf life), but for research‑grade vials, it is safer to aliquot and freeze at ‑80 °C to avoid repeated freeze‑thaw cycles. Never freeze the commercial pre‑filled form.
Yes. All clinical trials use subcutaneous injection once weekly. The MOMENTUM obesity trial used a standard 1 mL injection volume for the 2.4 mg dose.
Nausea affects 40‑55% of users at the 2.4 mg dose, peaking 1‑3 days after the weekly injection and easing over the rest of the week. This predictable window means you should schedule the injection for a time when post‑dose discomfort won't interfere with critical activities. The calculator's standard 28‑day tolerance assumption does not apply; GI adaptation takes 4‑8 weeks.
Practical takeaway: If your real goal is weight or metabolic health, the most useful next step is discussing approved treatment options with a clinician rather than relying on an unapproved compound.
Important: This tool is for informational and research-reference purposes only. Not intended for human or veterinary use.